EpiPen Familiarity May Prove Tough Hurdle For Generics
Executive Summary
With EpiPen injector patent-protected and patients accustomed to its use, finding a substitutable generic device may prove difficult.
You may also be interested in...
The History Behind The Drug-Device Combos Targeted By FTC
Of the 16 products whose Orange Book patent listings have been challenged by the FTC, six have no generic competitors and two faced first generic launches this year. A review of their patent and pricing battles shows the difficulties in developing generics for these complex drugs.
The History Behind The Drug-Device Combos Targeted By FTC
Of the 16 products whose Orange Book patent listings have been challenged by the FTC, six have no generic competitors and two faced first generic launches this year. A review of their patent and pricing battles shows the difficulties in developing generics for these complex drugs.
FDA Eyes Adverse Events For Mylan's Wixela Inhub
As patients log device complaints for Mylan’s Advair Diskus generic Wixela Inhub, the agency is assessing whether additional reminders about the products’ differences are needed.